The IV industry is booming, and for the first time ever, pioneers in the health and wellness space are coming together to give the industry more shape and prominence. Liquivida is one of the leading companies invited to speak at the industry’s first-ever IV Biz Bash in Orlando, Florida on October 14th and 15th, 2022.
For many, the conference marks the start of a viable industry that is taking off in a post-pandemic era. More and more doctors, nurses and medical practitioners are finding that IV therapy is a booming business with the power to make strides in wellness environments. The upcoming conference is a big step for the industry to receive attention nationwide. This is why Sam Tejada, the founder of Liquivida, was eager to step up to help.
As the idea for an IV industry conference was taking shape, Chris Himel, conference director and organizer, reached out to select names in the industry he knew he could trust to help lead the charge. Liquivida was one of the first industries considered, and one of the most responsive. Chris noted that Sam Tejada immediately reached out to ask how he could help, and how else he could be involved. Chris explained, “I just have a tremendous amount of respect for them, and what they do, and what they’ve built, and how he and Emmanuel and Jeff run that company.” Himel thought that Liquivida and their leadership were some of the professionals he needed to help participants get the most value from the conference experience.
“To me, the easiest way to learn is to learn from someone who has already done it.” Himel says in regards to his industry leader contacts. He wants people just starting out in the industry to see the success tactics of people who have already traveled the same roads with similar obstacles. In looking for experience, Liquivida, which has been consistently expanding their scope and their offerings within the IV industry and wellness field, was also one of the first to come to mind. Himel notes that they could have used celebrities to speak about the process, but he thought the attendees would get more value from the event by watching people who are already successful in their work.
Liquivida’s growth and marketing will actually be one of Sam Tejada’s main talking points during the conference. He will also share specific insights on what it takes to grow a mobile IV operation, to develop a corporate wellness outreach program, and to scale an IV practice through Liquivida’s IV kits, vial packets, or through Liquivida Wellness Centers, which have been named a Top Health and Wellness Franchise to Watch by Franchise Times magazine.
Sam will also serve on a panel for the biggest industry names to discuss the behind the scenes growing processes and the state of the industry from the top.
Himel notes that he has been both surprised and inspired that even competing businesses are coming together to better the industry. Everyone seems to be united under the idea that “the more people know about the industry, the better it is for everyone.” Gathering the cohesive, yet competing industry leaders together to discuss their experiences is the best way to disseminate information so that the industry can succeed as a whole.
The latest trending report Global Intravenous (IV) Ibuprofen Market 2020 by Manufacturers Regions Type and Application Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The global Intravenous (IV) Ibuprofen market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.9% in the forecast period of 2020 to 2025 and will expected to reach USD 10050 million by 2025, from USD 6658.5 million in 2019.The Intravenous (IV) Ibuprofen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/40349-intravenous-iv-ibuprofen-industry-analysis-reportThe major players covered in Intravenous (IV) Ibuprofen are:Cumberland PharmaceuticalsGloria PharmaceuticalsSandor MedicaidsAlveda PharmaceuticalsGrifols, CSL LimitedLaboratorios ValmorcaGermin MEDPT.
Soho Industri PharmasiAl Nabeel InternationalBy Type, Intravenous (IV) Ibuprofen market has been segmented into100 mg Dose200 mg Dose400 mg Dose800 mg DoseBy Application, Intravenous (IV) Ibuprofen has been segmented intoPainFeverInflammationThe report offers in-depth assessment of the growth and other aspects of the Intravenous (IV) Ibuprofen market in important countries (regions), includingNorth America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.
)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Intravenous (IV) Ibuprofen Market @ https://www.decisiondatabases.com/contact/download-sample-40349The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Intravenous (IV) Ibuprofen product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Intravenous (IV) Ibuprofen, with price, sales, revenue and global market share of Intravenous (IV) Ibuprofen in 2018 and 2019.Chapter 3, the Intravenous (IV) Ibuprofen competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Intravenous (IV) Ibuprofen breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Intravenous (IV) Ibuprofen market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Intravenous (IV) Ibuprofen sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Intravenous (IV) Ibuprofen Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-40349Other Reports by DecisionDatabases.com:Global Ibuprofen Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global Ketoprofen Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global NEOPROFEN Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024About-Us: DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details: DecisionDatabases.com E-Mail: [email protected] Phone: +91 9028057900 Web: https://www.decisiondatabases.com/
